XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Financial Instruments
 9 Months Ended
Sep. 30, 2024
Investments, All Other Investments [Abstract]  
Fair Value of Financial Instruments

Note 7 – Fair Value of Financial Instruments

 

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made.

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2024

 

The Company’s financial assets and liabilities measured at fair value on a recurring basis consisted of the following at September 30, 2024 and December 31, 2023, respectively:

 

Financial Assets and Liabilities Measured at Fair Value

      

Quoted Prices in

Active Markets for

   

Significant Other

Observable

  

Significant

Unobservable

 
       Identical Assets    Inputs   Inputs 
   September 30, 2024   (Level 1)    (Level 2)   (Level 3) 
                       
Exchange Traded Funds  $10,068,506   $ 10,068,506    $            -   $          - 

 

      

Quoted Prices in

Active Markets for

   

Significant Other

Observable

  

Significant

Unobservable

 
       Identical Assets    Inputs   Inputs 
   December 31, 2023   (Level 1)    (Level 2)   (Level 3) 
                       
Exchange Traded Funds  $-   $   -    $-   $-